Wall Street Next

latest news in economy

U.S. Economic Growth Plunges Below One Percent in Late 2025 as Consumers Pull Back

Washington, D.C., Friday, 13 March 2026.
U.S. economic growth slowed to a sluggish 0.7% in late 2025. A 43-day government shutdown and a sharp decline in consumer spending drove this concerning downward revision.

US Inflation Climbs to 3.1 Percent in January, Jeopardizing Expected Interest Rate Cuts

Washington, D.C., Friday, 13 March 2026.
US consumer prices unexpectedly accelerated to 3.1 percent in January 2026. This stubborn inflation erases recent economic progress and threatens to delay the Federal Reserve’s anticipated interest rate cuts.

Independent Women Drive a Historic Shift in US Real Estate

New York, Friday, 13 March 2026.
Single women now constitute 25% of first-time homebuyers, vastly outpacing single men. This historic shift in purchasing power signals a crucial evolution in domestic wealth building and housing markets.

Large Investors Accumulate TRUMP Tokens Amid Steep Price Declines

New York, Friday, 13 March 2026.
Despite a massive drop in value, large cryptocurrency investors increased their TRUMP token holdings by over 13 percent this week, revealing a surprising contrarian strategy among high-net-worth buyers.

Why Most American Small Businesses Are Running Out of Cash

New York, Thursday, 12 March 2026.
A staggering 63% of American small businesses are surviving on less than three months of cash. Rising operational costs and rigid financing barriers threaten broader economic stability in 2026.

Geopolitical Conflict Pushes U.S. Mortgage Rates Above Six Percent

New York, Thursday, 12 March 2026.
Sparked by the Iran conflict and surging oil prices, U.S. mortgage rates have jumped to 6.11%, abruptly ending a brief dip and threatening to cool domestic housing demand.

Foreign Pharmaceutical Plants Fail FDA Inspections at Nearly Twice the Domestic Rate

Washington, Thursday, 12 March 2026.
A new study reveals a critical supply chain vulnerability: foreign pharmaceutical facilities fail FDA inspections at up to 1.8 times the rate of domestic plants amid surging U.S. imports.